Horizon to Acquire US Rights for VIMOVO from Pozen
November 19, 2013 at 06:18 AM EST
POZEN (NASDAQ: POZN ) today announced that AstraZeneca AB (NYSE: AZN ) and Horizon Pharma USA, Inc. (NASDAQ: HZNP ) have entered into an agreement for Horizon to acquire the U.S.